Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Integra Lifesciences Holdings Corp shares valued at $1,499,979 were purchased by ESSIG STUART on May 23 ’24. At $28.49 per share, ESSIG STUART acquired 52,641 shares. The insider’s holdings grew to 487,922 shares worth approximately $10.67 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, HILL BARBARA B purchased 36,350 shares, netting a total of over 995,816 in proceeds. Following the buying of shares at $27.40 each, the insider now holds 36,350 shares.
Before that, DAVIS ROBERT T. JR. had sold 8,348 shares from its account. In a trade valued at $305,492, the EVP & President, TT traded Integra Lifesciences Holdings Corp shares for $36.59 each. Upon closing the transaction, the insider’s holdings decreased to 8,348 shares, worth approximately $1.09 million.
As published in a research note from Citigroup on July 30, 2024, Integra Lifesciences Holdings Corp [IART] has been rated down from a Neutral to a Sell and the price target has been revised to $23 from $30. Analysts at BTIG Research downgraded the stock from ‘”a Neutral”‘ to ‘”a Sell”‘ outlook in a report released in late July. As of May 07, 2024, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for IART. Earlier on May 07, 2024, Oppenheimer downgraded its rating. Their new recommendation was “a Perform” for IART stock which previously was a “an Outperform”.
Analyzing IART Stock Performance
During the last five days, there has been a surge of approximately 0.37%. Over the course of the year, Integra Lifesciences Holdings Corp shares have dropped approximately -49.80%. Shares of the company reached a 52-week high of $45.42 on 02/20/24 and a 52-week low of $21.08 on 08/12/24. A 50-day SMA is recorded $27.98, while a 200-day SMA reached $34.66. Nevertheless, trading volume fell to 0.94 million shares from 1.01 million shares the previous day.
Support And Resistance Levels for Integra Lifesciences Holdings Corp (IART)
According to the 24-hour chart, there is a support level at 21.60, which, if violated, would cause prices to drop to 21.35. In the upper region, resistance lies at 22.09. The next price resistance is at 22.32. RSI (Relative Strength Index) is 27.69 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.28, which suggests the price will decrease in the coming days. Percent R is at 87.25%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.
